Inequities in Therapy for Infantile Spasms: A Call to Action
- 28 April 2022
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 92 (1), 32-44
- https://doi.org/10.1002/ana.26363
Abstract
Objective The aim of this study was to determine whether selection of treatment for children with infantile spasms (IS) varies by race/ethnicity. Methods The prospective US National Infantile Spasms Consortium database includes children with IS treated from 2012 to 2018. We examined the relationship between race/ethnicity and receipt of standard IS therapy (prednisolone, adrenocorticotropic hormone, vigabatrin), adjusting for demographic and clinical variables using logistic regression. Our primary outcome was treatment course, which considered therapy prescribed for the first and, when needed, the second IS treatment together. Results Of 555 children, 324 (58%) were non-Hispanic white, 55 (10%) non-Hispanic Black, 24 (4%) non-Hispanic Asian, 80 (14%) Hispanic, and 72 (13%) other/unknown. Most (398, 72%) received a standard treatment course. Insurance type, geographic location, history of prematurity, prior seizures, developmental delay or regression, abnormal head circumference, hypsarrhythmia, and IS etiologies were associated with standard therapy. In adjusted models, non-Hispanic Black children had lower odds of receiving a standard treatment course compared with non-Hispanic white children (odds ratio [OR], 0.42; 95% confidence interval [CI], 0.20-0.89; p = 0.02). Adjusted models also showed that children with public (vs. private) insurance had lower odds of receiving standard therapy for treatment 1 (OR, 0.42; CI, 0.21-0.84; p = 0.01). Interpretation Non-Hispanic Black children were more often treated with non-standard IS therapies than non-Hispanic white children. Likewise, children with public (vs. private) insurance were less likely to receive standard therapies. Investigating drivers of inequities, and understanding the impact of racism on treatment decisions, are critical next steps to improve care for patients with IS. ANN NEUROL 2022Funding Information
- American Epilepsy Society
- National Institute of Neurological Disorders and Stroke (K23NS116110)
- Pediatric Epilepsy Research Foundation
This publication has 47 references indexed in Scilit:
- Time to pediatric epilepsy surgery is related to disease severity and nonclinical factorsNeurology, 2013
- Evidence-based guideline update: Medical treatment of infantile spasmsNeurology, 2012
- Detecting health disparities among Caucasians and African-Americans with epilepsyEpilepsy & Behavior, 2011
- Infantile spasms: A U.S. consensus reportEpilepsia, 2010
- Disparities in epilepsy: Report of a systematic review by the North American Commission of the International League Against EpilepsyEpilepsia, 2009
- Sociodemographic disparities in epilepsy care: Results from the Houston/New York City health care use and outcomes studyEpilepsia, 2009
- Vigabatrin: 2008 UpdateEpilepsia, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008
- Intractable pediatric temporal lobe epilepsy in the United States: examination of race, age, sex, and insurance status as factors predicting receipt of resective treatmentJournal of Neurosurgery: Pediatrics, 2007
- Patient Race/Ethnicity and Quality of Patient–Physician Communication During Medical VisitsAmerican Journal of Public Health, 2004